- Home
- NEUP vs OGEN Comparison
NEUP vs OGEN Comparison
Compare NEUP & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- OGEN
- Stock Information
- Founded
- NEUP 1996
- OGEN 1996
- Country
- NEUP United States
- OGEN United States
- Employees
- NEUP N/A
- OGEN N/A
- Industry
- NEUP
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- NEUP
- OGEN Health Care
- Exchange
- NEUP Nasdaq
- OGEN Nasdaq
- Market Cap
- NEUP 5.5M
- OGEN 5.5M
- IPO Year
- NEUP N/A
- OGEN N/A
- Fundamental
- Price
- NEUP $3.15
- OGEN $0.28
- Analyst Decision
- NEUP
- OGEN
- Analyst Count
- NEUP 0
- OGEN 0
- Target Price
- NEUP N/A
- OGEN N/A
- AVG Volume (30 Days)
- NEUP 625.4K
- OGEN 1.7M
- Earning Date
- NEUP 02-13-2025
- OGEN 11-13-2024
- Dividend Yield
- NEUP N/A
- OGEN N/A
- EPS Growth
- NEUP N/A
- OGEN N/A
- EPS
- NEUP N/A
- OGEN N/A
- Revenue
- NEUP N/A
- OGEN N/A
- Revenue This Year
- NEUP N/A
- OGEN N/A
- Revenue Next Year
- NEUP N/A
- OGEN N/A
- P/E Ratio
- NEUP N/A
- OGEN N/A
- Revenue Growth
- NEUP N/A
- OGEN N/A
- 52 Week Low
- NEUP $2.12
- OGEN $0.25
- 52 Week High
- NEUP $16.08
- OGEN $6.22
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- OGEN 38.94
- Support Level
- NEUP N/A
- OGEN $0.34
- Resistance Level
- NEUP N/A
- OGEN $0.42
- Average True Range (ATR)
- NEUP 0.00
- OGEN 0.05
- MACD
- NEUP 0.00
- OGEN -0.01
- Stochastic Oscillator
- NEUP 0.00
- OGEN 5.05
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's lead product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification.